Want to see PAYS full AI Analyst Report?
PAYS Stock Chart & Stats
$8.69
$0.19(2.19%)
At close: 4:00 PM EDT
$8.69
$0.19(2.19%)
Day’s Range― - ―
52-Week Range$3.08 - $14.25
Previous CloseN/A
Volume152.25K
Average Volume (3M)554.91K
Market Cap
$780.31M
Enterprise Value$336.81
Total Cash (Recent Filing)$27.37M
Total Debt (Recent Filing)$5.71M
Price to Earnings (P/E)49.4
Beta1.82
Next Earnings
Nov 10, 2026EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.29
Shares Outstanding56,462,154
10 Day Avg. Volume537,909
30 Day Avg. Volume554,912
Financial Highlights & Ratios
PEG Ratio0.39
Price to Book (P/B)5.78
Price to Sales (P/S)3.42
P/FCF Ratio5.47
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$12.88Price Target Upside48.16% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)0.24
Revenue Forecast (FY)$113.47M
Bulls Say, Bears Say
Bulls Say
Patient Affordability GrowthRapid growth in patient affordability revenue, claims, and program count strengthens PaySign’s higher-growth pharma vertical. Expanding sponsor relationships and financial-assistance volumes can support recurring program fees and transaction revenue over the next several quarters.
Margin Expansion And Operating LeverageRevenue is growing faster than operating expenses, while mix is shifting toward higher-margin pharma programs. Sustained cost discipline and scale could support durable profitability and allow incremental revenue to convert more efficiently into earnings.
Strong Cash Generation And Low LeverageHigh operating and free cash flow, combined with very limited leverage, gives PaySign substantial financial flexibility. Internal funding can support product investment, acquisitions, or shareholder returns without creating significant balance-sheet strain.
Bears Say
Plasma Center Attrition And Customer ConcentrationA lower plasma-center base can reduce recurring program activity and transaction volumes, particularly where customers are concentrated. Closures and competitive transfers also indicate that growth in this vertical may be less predictable than headline revenue trends suggest.
SaaS/app Revenue Timing UncertaintyThe product could broaden PaySign’s addressable market and diversify revenue, but regulatory engagement delays commercialization. Until approval and adoption are clearer, expected SaaS contribution remains uncertain and cannot reliably offset pressure in existing programs.
Growth Normalization And Margin VariabilityGrowth is cooling from the company’s earlier acceleration, and seasonal pharma-to-plasma mix changes may reduce margins during parts of the year. This creates execution risk against ambitious targets and makes sustained margin expansion less certain.
Paysign News
PAYS FAQ
What was Paysign, Inc.’s price range in the past 12 months?
Paysign, Inc. lowest stock price was $3.08 and its highest was $14.25 in the past 12 months.
What is Paysign, Inc.’s market cap?
Paysign, Inc.’s market cap is $780.31M.
When is Paysign, Inc.’s upcoming earnings report date?
Paysign, Inc.’s upcoming earnings report date is Nov 10, 2026 which is in 80 days.
How were Paysign, Inc.’s earnings last quarter?
Paysign, Inc. released its earnings results on Aug 05, 2026. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.06 by $0.05.
Is Paysign, Inc. overvalued?
According to Wall Street analysts Paysign, Inc.’s price is currently Undervalued.
Does Paysign, Inc. pay dividends?
Paysign, Inc. does not currently pay dividends.
What is Paysign, Inc.’s EPS estimate?
Paysign, Inc.’s EPS estimate is 0.09.
How many shares outstanding does Paysign, Inc. have?
Paysign, Inc. has 56,462,154 shares outstanding.
What happened to Paysign, Inc.’s price movement after its last earnings report?
Paysign, Inc. reported an EPS of $0.11 in its last earnings report, beating expectations of $0.06. Following the earnings report the stock price went up 29.301%.
Which hedge fund is a major shareholder of Paysign, Inc.?
Currently, no hedge funds are holding shares in PAYS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Paysign Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$12.88 (48.16% Upside)
$12.88 (48.16% Upside)
Blogger Sentiment
Bullish
PAYS Sentiment 67%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 171.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $583.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 5.2%
Last 30 Days ▼ 5.2%
Technicals
SMA
Positive
20 days / 200 days
Momentum
1.51%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
63.48%
Trailing 12-Months
Company Description
Paysign, Inc.
PaySign, Inc. (PAYS) is a U.S.-based financial technology company in the payments and prepaid card sector. The company provides payment solutions centered on prepaid debit card programs, including card issuance and program management services, with a focus on corporate/rebate and healthcare-related disbursements.
PAYS Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlighted a very strong quarter: substantial revenue and profit growth, wide margin expansion, a robust pharma pipeline, and continued plasma revenue expansion and cash generation. Management reiterated confident full-year guidance and plans to exceed prior program-addition performance. Key risks discussed include a lower-than-guided plasma center count (due to sales/closures), the SaaS/app not yet producing revenue (FDA engagement ongoing), a higher effective tax rate, and margin variability driven by seasonal mix. Overall the positives (large percentage growth across revenue, EBITDA, operating margin, patient assistance dollars, and pipeline strength) substantially outweigh the operational and timing-related lowlights.View all PAYS earnings summariesPAYS Stock 12 Month Forecast
Average Price Target
$12.88
▲(48.16% Upside)
Technical Analysis
International Money Express
―
Repay Holdings
―
AvePoint
―
Payoneer
―
Bakkt Holdings, Inc. Class A
―
Ownership Overview
21.26% Insiders
7.35% Mutual Funds
21.74% Other Institutional Investors
40.68% Public Companies and Individual Investors